Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

7.36
Delayed Data
As of 3:59pm ET
 +0.09 / +1.24%
Today’s Change
6.23
Today|||52-Week Range
29.93
-51.42%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close7.27
Today’s open7.15
Day’s range7.15 - 7.48
Volume708,423
Average volume (3 months)603,703
Market cap$299.2M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-110.91%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+2.73%
P/E ratio--
Price/Sales0.89
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--CRH Medical Corp-0.19-3.87%
--Cynapsus Therapeutic...-0.05-0.24%
--Merus Labs Internati...-0.01-0.45%
--Cardiome Pharma Corp-0.01-0.09%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.41
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin132.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts

Partner Offers